135 related articles for article (PubMed ID: 333856)
1. Bromocriptine in the treatment of advanced Parkinsonism.
Kristensen O; Hansen E
Acta Neurol Scand; 1977 Sep; 56(3):274-6. PubMed ID: 333856
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Gron U
Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
[TBL] [Abstract][Full Text] [Related]
4. Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
Jansen EN
Eur Neurol; 1978; 17(2):92-9. PubMed ID: 344042
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine: low-dose therapy in Parkinson disease.
Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
[TBL] [Abstract][Full Text] [Related]
6. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
7. Combined bromocriptine-levodopa therapy early in Parkinson's disease.
Rinne UK
Neurology; 1985 Aug; 35(8):1196-8. PubMed ID: 4022354
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic agonists in Parkinsonism.
Claveria LE; Teychenne PF; Calne DB; Petrie A; Bassendine MF
Adv Neurol; 1975; 9():383-92. PubMed ID: 1096576
[No Abstract] [Full Text] [Related]
9. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
Hely MA; Morris JG; Reid WG; O'Sullivan DJ; Williamson PM; Rail D; Broe GA; Margrie S
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):903-10. PubMed ID: 8057111
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Parkes JD; Debono AG; Marsden CD
J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic parkinsonism treated with bromocriptine.
Teychenne PF; Leigh PN; Reid JL; Calne DB; Greenacre JK; Petrie A; Bamji AN
Lancet; 1975 Sep; 2(7933):473-6. PubMed ID: 51285
[TBL] [Abstract][Full Text] [Related]
12. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pergolide and bromocriptine therapy in parkinsonism.
LeWitt PA; Ward CD; Larsen TA; Raphaelson MI; Newman RP; Foster N; Dambrosia JM; Calne DB
Neurology; 1983 Aug; 33(8):1009-14. PubMed ID: 6348585
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
Godwin-Austen RB; Smith NJ
J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
[TBL] [Abstract][Full Text] [Related]
15. Effects of bromocriptine on parkinsonism. A nation-wide collaborative double-blind study.
Toyokura Y; Mizuno Y; Kase M; Sobue I; Kuroiwa Y; Narabayashi H; Uono M; Nakanishi T; Kameyama M; Ito H
Acta Neurol Scand; 1985 Aug; 72(2):157-70. PubMed ID: 3901650
[TBL] [Abstract][Full Text] [Related]
16. Ropinirole: a review of its use in the management of Parkinson's disease.
Matheson AJ; Spencer CM
Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932
[TBL] [Abstract][Full Text] [Related]
17. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of bromocriptine in the treatment of Parkinson's disease.
Mackenzie RA; Lance JW
Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
Laihinen A; Rinne UK; Suchy I
Acta Neurol Scand; 1992 Dec; 86(6):593-5. PubMed ID: 1481646
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
Montastruc JL; Rascol O; Rascol A
Rev Neurol (Paris); 1990; 146(2):144-7. PubMed ID: 2181588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]